Polyclonal Rabbit anti‑Human SIGLEC5 / CD170 Antibody (aa482‑513, WB) LS‑C328661
Polyclonal Rabbit anti‑Human SIGLEC5 / CD170 Antibody (aa482‑513, WB) LS‑C328661
Antibody:
SIGLEC5 / CD170 Rabbit anti-Human Polyclonal (aa482-513) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
SIGLEC5 / CD170 Rabbit anti-Human Polyclonal (aa482-513) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
CD170 antibody LS-C328661 is an unconjugated rabbit polyclonal antibody to CD170 (SIGLEC5) (aa482-513) from human. It is reactive with human and mouse. Validated for ELISA and WB.
Target
Human SIGLEC5 / CD170
Synonyms
SIGLEC5 | CD170 antigen | CD170 | CD33 antigen-like 2 | OB-binding protein 2 | SIGLEC-5 | CD33L2 | OB-BP2 | OBBP2 | Obesity-binding protein 2
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
Biotin,
FITC,
HRP,
PE.
Purification
Affinity purified
Modifications
Unmodified.
Also available
Azide-free.
Specificity
This SIGLEC5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 482-513 amino acids from the C-terminal region of human SIGLEC5.
Applications
- Western blot (1:100 - 1:500)
- ELISA (1:1000)
Presentation
PBS, 0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse
Applications:
IHC, Western blot, ELISA
Species:
Human, Mouse
Applications:
Western blot
Species:
Human, Mouse
Applications:
IHC, Western blot, ELISA
Reactivity:
Human
Range:
3.125-800 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/19/2024